Phosphorylation of extracellular signal-regulated kinase (ERK)-1/2 is associated with the downregulation of peroxisome proliferator-activated receptor (PPAR)-γ during polymicrobial sepsis

Molecular Medicine

Volumn 16, Issue 11-12, 2010, Pages 491-497

  Kaplan, Jennifer M ^a   Hake, Paul W ^a   Denenberg, Alvin ^a   Nowell, Marchele ^a   Piraino, Giovanna ^a   Zingarelli, Basilia ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ADIPONECTIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; INFLAMMATION; LUNG INJURY; MALE; MOLECULAR MECHANICS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SEPSIS;

ADIPONECTIN; ANIMALS; ANTI-INFLAMMATORY AGENTS; DOWN-REGULATION; LIGANDS; LUNG; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PPAR GAMMA; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; TRANSCRIPTION FACTORS;

EID: 78149263130     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2010.00063     Document Type: Article

References (29)

1. Zingarelli B, et al. (2003) Peroxisome proliferator activator receptor-gamma ligands, 15-deoxydelta(12,14)-prostaglandin J2 and ciglitazone, reduce systemic inflammation in polymicrobial sepsis by modulation of signal transduction pathways. J. Immunol. 171:6827-37.
2. Kaplan JM, et al. (2005) 15-Deoxy-delta12,14- prostaglandin J2 (15D-PGJ2), a peroxisome proliferator activated receptor gamma ligand, reduces tissue leukosequestration and mortality in endotoxic shock. Shock 24:59-65.
3. Collin M, Patel NS, Dugo L, Thiemermann C. (2004) Role of peroxisome proliferator-activated receptor-gamma in the protection afforded by 15- deoxydelta12,14 prostaglandin J2 against the multiple organ failure caused by endotoxin. Crit. Care Med. 32:826-31.
4. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. (1998) The peroxisome proliferator-activated receptor- gamma is a negative regulator of macrophage activation. Nature 391:79-82.
5. Hill MR, Young MD, McCurdy CM, Gimble JM. (1997) Decreased expression of murine PPARgamma in adipose tissue during endotoxemia. Endocrinology 138:3073-6.
6. Tanaka T, et al. (1999) Down regulation of peroxisome proliferator-activated receptor gamma expression by inflammatory cytokines and its reversal by thiazolidinediones. Diabetologia 42:702-10.
7. Han J, et al. (2000) Transforming growth factorbeta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma. J. Biol. Chem. 275:1241-6.
8. Camp HS, Tafuri SR. (1997) Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase. J. Biol. Chem. 272:10811-6.
9. Adams M, Reginato MJ, Shao D, Lazar MA, Chatterjee VK. (1997) Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site. J. Biol. Chem. 272:5128-32.
10. Hauser S, et al. (2000) Degradation of the peroxisome proliferator-activated receptor gamma is linked to ligand-dependent activation. J. Biol. Chem. 275:18527-33.
11. Tanabe Y, Koga M, Saito M, Matsunaga Y, Nakayama K. (2004) Inhibition of adipocyte differentiation by mechanical stretching through ERK-mediated downregulation of PPARgamma2. J. Cell Sci. 117:3605-14.
12. Liu D, et al. (2005) Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, reduces acute lung injury in endotoxemic rats. Crit. Care Med. 33:2309-16.
13. RA. (2000) Pathogenesis and management of multiple organ dysfunction or failure in severe sepsis and septic shock. Crit. Care Clin. 16:337-52, vii.
14. Yang B, et al. (2004) Serum adiponectin as a biomarker for in vivo PPARgamma activation and PPARgamma agonist-induced efficacy on insulin sensitization/lipid lowering in rats. BMC Pharmacol. 4:23.
15. Kaplan JM, et al. (2010) Changes in peroxisome proliferator-activated receptor-gamma activity in children with septic shock. Intensive Care Med. 36:123-30.
16. Zhou M, Wu R, Dong W, Jacob A, Wang P. (2008) Endotoxin downregulates peroxisome proliferator- activated receptor-gamma via the increase in TNF-alpha release. Am. J. Physiol. Regul. Integr. Comp. Physiol. 294:R84-92.
17. Leininger MT, Portocarrero CP, Houseknecht KL. (1999) Peroxisome proliferator-activated receptor gamma1 expression in porcine white blood cells: dynamic regulation with acute endotoxemia. Biochem. Biophys. Res. Commun. 263:749-53.
18. Soller M, et al. (2006) Peroxisome proliferator-activated receptor gamma contributes to T lymphocyte apoptosis during sepsis. J. Leukoc. Biol. 79:235-43.
19. Vish MG, et al. (2007) Proinsulin c-peptide exerts beneficial effects in endotoxic shock in mice. Crit. Care Med. 35:1348-55.
20. Hu E, Kim JB, Sarraf P, Spiegelman BM. (1996) Inhibition of adipogenesis through MAP kinasemediated phosphorylation of PPARgamma. Science 274:2100-3.
21. Moon HS, et al. (2010) Alpha-eleostearic acid suppresses proliferation of MCF-7 breast cancer cells via activation of PPARgamma and inhibition of ERK 1/2. Cancer Sci. 101:396-402.
22. Burgermeister E, et al. (2007) Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor gamma. Mol. Cell. Biol. 27:803-17.
23. Iwaki M, et al. (2003) Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 52:1655-63.
24. Ouchi N, et al. (1999) Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100:2473-6.
25. Yokota T, et al. (2000) Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96:1723-32.
26. Tsuchihashi H, et al. (2006) Circulating concentrations of adiponectin, an endogenous lipopolysaccharide neutralizing protein, decrease in rats with polymicrobial sepsis. J. Surg. Res. 134:348-53.
27. Maeda N, et al. (2001) PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50:2094-9.
28. Combs TP, et al. (2002) Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrinology 143:998-1007.
29. Yu JG, et al. (2002) The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 51:2968-74.